Biomarkers For Prostate Cancer
First Claim
Patent Images
1. A method for characterizing prostate tissue in a subject, comprising:
- a) providing a sample from a subject suspected of having prostate cancer; and
b) detecting the presence or absence of expression of NLGN-4Y in said sample, thereby characterizing said prostate tissue sample.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy).
64 Citations
16 Claims
-
1. A method for characterizing prostate tissue in a subject, comprising:
-
a) providing a sample from a subject suspected of having prostate cancer; and b) detecting the presence or absence of expression of NLGN-4Y in said sample, thereby characterizing said prostate tissue sample. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A method of screening compounds, comprising:
-
a) providing i) a prostate cell sample; and ii) one or more test compounds; and b) contacting said prostate cell sample with said test compound; and c) detecting a change in NLGN-4Y expression in said prostate cell sample in the presence of said test compound relative to the absence of said test compound. - View Dependent Claims (11, 12, 13, 14, 15, 16)
-
Specification